Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Effectiveness and Safety of Naporafenib Combinations in Patients with Previously Treated Unresectable or Metastatic Melanoma

    Not recruiting

    1 1
    Investigated diseases:
    Belgium France Germany Italy
  • Study on the Effects of EVX-01 and Pembrolizumab in Adults with Advanced Melanoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on Detecting Untreated Brain Metastases in Lung, Breast, and Melanoma Cancer Patients Using Fluorodopa (18F)

    Not recruiting

    1 1 1
    Investigated drugs:
    France
  • Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials

    Not recruiting

    1 1 1 1
    Belgium Czechia France Germany Greece Hungary +5
  • Study on the Safety and Effects of ICT01, Aldesleukin, and Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1
    Investigated diseases:
    France Germany
  • Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

    Not recruiting

    1 1
    Investigated drugs:
    Greece Hungary Romania
  • Study on the Safety and Effectiveness of Pembrolizumab, Lenvatinib, and Quavonlimab for Patients with Advanced Melanoma with Brain Metastases

    Not recruiting

    1 1 1
    France Greece Hungary Italy Poland Spain
  • Study on Botensilimab and Balstilimab for Patients with Advanced Melanoma Resistant to Previous Treatments

    Not recruiting

    1 1
    Investigated drugs:
    Belgium France Germany Italy Spain
  • Study of Subcutaneous Nivolumab with or without Recombinant Human Hyaluronidase PH20 for Patients with Lung, Kidney, Melanoma, Liver, Colorectal, or Bladder Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    France Italy The Netherlands Poland Spain
  • Study on Nemvaleukin Alfa and Pembrolizumab for Patients with Advanced Skin or Mucosal Melanoma

    Not recruiting

    1 1 1
    Italy Spain